by adminTorusBrand | Feb 14, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Media Coverage
Medical Marijuana, Inc. VP of Operations Blake Schroeder and Andrew Hard, CEO of CMW Media, sat down with Drew Schlosberg of the San Diego Union-Tribune Community Spotlight late last week to discuss the cannabis industry and Medical Marijuana, Inc.’s role as a proven...
by adminTorusBrand | Feb 13, 2017 | HempMeds, Press Releases
Customers Now Have Ability to Earn Commissions Based on New Customer Referrals SAN DIEGO, Feb. 13, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® is...
by adminTorusBrand | Feb 13, 2017 | HempMeds, Press Releases
Customers Now Have Ability to Earn Commissions Based on New Customer Referrals SAN DIEGO, Feb. 13, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary HempMeds® is...
by adminTorusBrand | Jan 17, 2017 | HempMeds, Kannaway, Press Releases
SAN DIEGO, Jan. 17, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Dirk Syburra has been promoted to Vice President of Data & Technology for the company....
by adminTorusBrand | Jan 11, 2017 | HempMeds, Media Coverage, Press Releases
Interview Portrays the Benefits of Cannabis-Related Products to Millions of Chinese Viewers Around the World SAN DIEGO, Jan. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) is pleased to announce that the Company’s CEO was featured in a series...
by adminTorusBrand | Jan 3, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Industry Updates, Kannalife Sciences
[vc_row][vc_column][vc_column_text]When looking back on 2016, it is hard to imagine a world where continued cannabis legalization, soaring cannabis approval ratings, and increased demand for cannabis research were not the norm. This year, the U.S. added four new...
